StockGlow

Diamyd Medical AB (publ) (DMYD-B.ST)

Diamyd Medical AB (publ) develops precision medicine therapies for the treatment of autoimmune diabetes.

1.03+0.00%Healthcare
Compare DMYD-B.ST with
StockGlow Score
19
Bearish
BearishBullish
1 year ago-90.4%

The outlook

Diamyd Medical AB (publ) currently reads as bearish based on below its 50- & 200-day averages, 1% of the way from its 52-week low to high, avg target +36% vs current price. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range1% of the way from its 52-week low to high
Price targetAvg target +36% vs current price
Market cap
$159.6M
52-wk high
17.88
52-wk low
0.90
50-day avg
1.09
200-day avg
7.53
Trailing P/E
—

Similar stocks

CANTA.STCantargia AB (publ)$1.82+0.33%HNSA.STHansa Biopharma AB (publ)$34.40+0.29%SANION.STSaniona AB (publ)$14.23+1.79%NXTCL.STNextCell Pharma AB$1.13+1.26%ONCO.STOncopeptides AB (publ)$1.58-0.13%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy